As part of our upcoming plenary session at the July SRS meeting, we are proud to spotlight a group of companies helping shape the future of surgery, procedural medicine, and intelligent operating rooms. Their work spans incisionless therapy, focused ultrasound, robotic treatment platforms, surgical augmented reality, AI infrastructure, digital workflow, and connected operating room ecosystems. Together, these organizations reflect the direction modern procedural care is heading: precise, less invasive, data-driven, and autonomous.
This session is designed not only to showcase technology, but also to highlight a broader vision for the future of surgery: one in which energy-based treatment, image guidance, robotics, artificial intelligence, and surgical data platforms work together to improve outcomes and expand what is possible for patients and clinicians alike.
Featured Companies
- HistoSonics: HistoSonics is advancing non-invasive therapy through histotripsy, a focused ultrasound approach that uses acoustic cavitation to mechanically destroy targeted tissue without incisions, needles, radiation, or heat-based ablation. The company’s Edison platform has been developed for the non-invasive mechanical destruction of liver tumors, making HistoSonics one of the most important names in the fast-growing field of incisionless therapy.
- Petal Surgical: Petal Surgical is a surgical technology company focused on making incisionless surgery a broader reality. The company describes its platform as “Acoustic Sculpting,” a proprietary form of Millisecond Pulse Histotripsy, and presents its mission as moving interventional care beyond conventional invasive tissue manipulation. Its presence in this session represents the next frontier of noninvasive procedural innovation.
- NVIDIA: NVIDIA brings the computational backbone that is increasingly driving modern healthcare innovation. Its healthcare and life sciences platform supports AI development across medical imaging, digital health, robotics, genomics, and medtech, and it has also launched generative AI microservices aimed at accelerating medical-device, drug-discovery, and healthcare applications. For a meeting centered on the future of surgery, NVIDIA represents the enabling layer behind many of the advances clinicians will increasingly use.
- InSightec: InSightec is a pioneer in focused ultrasound and has helped establish incisionless therapy as a real clinical option rather than a future concept. Its Exablate platforms use focused ultrasound, often with MRI guidance, to deliver precision treatment without surgical incisions, and the company highlights current applications including essential tremor and tremor-dominant Parkinson’s disease. InSightec exemplifies how energy-based therapy is redefining procedural care.
- SurgAR: SurgAR is a medtech company focused on bringing computer vision and augmented reality into surgery. The company describes its mission as transforming computer vision research into augmented-reality solutions that enhance minimally invasive surgery. Its participation is especially relevant to audiences interested in how digital overlays, image guidance, and intraoperative visualization can improve precision and surgical decision-making.
- Brainlab: Brainlab has long been a leader in digital surgery, navigation, and integrated operating room systems. The company’s software and hardware are designed to improve critical surgeries, radiosurgery, and operating room efficiency, while its integrated OR platform brings communication, documentation, and clinical data into one environment. Brainlab’s role in this plenary session highlights the importance of connected infrastructure in the OR of the future.
- Profound Medical: Profound Medical is developing and commercializing incision-free therapeutic platforms including TULSA-PRO and Sonalleve. TULSA-PRO is designed for customizable prostate tissue ablation with active protection of critical surrounding structures, while Sonalleve offers incision-free options in areas such as uterine fibroids and palliative treatment of pain from bone metastases. Profound represents the expansion of precise, image-guided ablation into multiple clinical domains.
- PROCEPT BioRobotics: PROCEPT BioRobotics is known for Aquablation therapy, an ultrasound-guided, robotic-assisted, heat-free waterjet treatment for BPH. The company positions Aquablation as a precise and predictable option across prostates of different shapes and sizes, with newer platform features including AI-powered treatment planning. PROCEPT’s inclusion reflects the growing role of robotics and intelligent planning in urologic intervention.